Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2009 Competitiveness Can Undermine Team Goals, Commentary 2 Laurel C. Blakemore, MD Competitive behaviors can undermine a clerkship student’s residency goals and weaken team collaboration and communication. Virtual Mentor. 2009; 11(5):370-372. doi: 10.1001/virtualmentor.2009.11.5.ccas3-0905. Health Law Sep 2009 A Physician's Duty to Warn Third Parties of Hereditary Risk Kristin E. Schleiter, JD, LLM Two key court decisions came to different conclusions regarding physicians’ duty to warn third parties of genetic risk. Virtual Mentor. 2009; 11(9):697-700. doi: 10.1001/virtualmentor.2009.11.9.hlaw1-0909. AMA Code Says Sep 2009 AMA Code of Medical Ethics’ Opinions on Genetic Testing AMA Council on Ethical and Judicial Affairs When a child is being considered for adoption, the guidelines for genetic testing should be the same as for other children. Virtual Mentor. 2009; 11(9):683-685. doi: 10.1001/virtualmentor.2009.11.9.code1-0909. State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Physicians should look for specific clinical evidence when examining a patient suspected of anabolic steroid use. Virtual Mentor. 2004; 6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407 Case and Commentary Dec 2004 Confusion over Cholesterol Testing, Commentary 1 Kenneth W. Goodman, PhD Physicians must stay up-to-date on changes in clinical treatment guidelines. Virtual Mentor. 2004; 6(12):536-538. doi: 10.1001/virtualmentor.2004.6.12.ccas2-0412. Case and Commentary Dec 2004 Confusion over Cholesterol Testing, Commentary 2 Eta S. Berner, EdD Physicians must stay up-to-date on changes in clinical treatment guidelines. Virtual Mentor. 2004; 6(12):539-541. doi: 10.1001/virtualmentor.2004.6.12.ccas2-0412. Case and Commentary Aug 2004 Helping Surrogate Decision Makers in the Face of Uncertainty Robert W. Taylor, MD Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication. Virtual Mentor. 2004; 6(8):342-344. doi: 10.1001/virtualmentor.2004.6.8.ccas2-0408. In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004; 6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004; 6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004; 6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Pagination First page « First Previous page ‹ Previous … Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Next page Next › Last page Last »
Case and Commentary May 2009 Competitiveness Can Undermine Team Goals, Commentary 2 Laurel C. Blakemore, MD Competitive behaviors can undermine a clerkship student’s residency goals and weaken team collaboration and communication. Virtual Mentor. 2009; 11(5):370-372. doi: 10.1001/virtualmentor.2009.11.5.ccas3-0905.
Health Law Sep 2009 A Physician's Duty to Warn Third Parties of Hereditary Risk Kristin E. Schleiter, JD, LLM Two key court decisions came to different conclusions regarding physicians’ duty to warn third parties of genetic risk. Virtual Mentor. 2009; 11(9):697-700. doi: 10.1001/virtualmentor.2009.11.9.hlaw1-0909.
AMA Code Says Sep 2009 AMA Code of Medical Ethics’ Opinions on Genetic Testing AMA Council on Ethical and Judicial Affairs When a child is being considered for adoption, the guidelines for genetic testing should be the same as for other children. Virtual Mentor. 2009; 11(9):683-685. doi: 10.1001/virtualmentor.2009.11.9.code1-0909.
State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Physicians should look for specific clinical evidence when examining a patient suspected of anabolic steroid use. Virtual Mentor. 2004; 6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407
Case and Commentary Dec 2004 Confusion over Cholesterol Testing, Commentary 1 Kenneth W. Goodman, PhD Physicians must stay up-to-date on changes in clinical treatment guidelines. Virtual Mentor. 2004; 6(12):536-538. doi: 10.1001/virtualmentor.2004.6.12.ccas2-0412.
Case and Commentary Dec 2004 Confusion over Cholesterol Testing, Commentary 2 Eta S. Berner, EdD Physicians must stay up-to-date on changes in clinical treatment guidelines. Virtual Mentor. 2004; 6(12):539-541. doi: 10.1001/virtualmentor.2004.6.12.ccas2-0412.
Case and Commentary Aug 2004 Helping Surrogate Decision Makers in the Face of Uncertainty Robert W. Taylor, MD Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication. Virtual Mentor. 2004; 6(8):342-344. doi: 10.1001/virtualmentor.2004.6.8.ccas2-0408.
In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004; 6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004; 6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004; 6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.